Literature DB >> 16753405

Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study.

Varant Kupelian1, Ridwan Shabsigh, Andre B Araujo, Amy B O'Donnell, John B McKinlay.   

Abstract

PURPOSE: The metabolic syndrome, characterized by central obesity, insulin dysregulation, abnormal lipids and borderline hypertension, is a precursor state for cardiovascular disease. We determined whether erectile dysfunction is predictive of the metabolic syndrome.
MATERIALS AND METHODS: Data were obtained from the Massachusetts Male Aging Study, a population based prospective cohort observed at 3 points during approximately 15 years (T(1)-1987 to 1989, T(2)-1995 to 1997, T(3)-2002 to 2004). The metabolic syndrome was defined by using a modification of the Adult Treatment Panel III guidelines. The association between erectile dysfunction and the metabolic syndrome was assessed using relative risks and 95% confidence intervals estimated using Poisson regression models.
RESULTS: Analysis was conducted of 928 men without the metabolic syndrome at T(1). There were 293 men with incident metabolic syndrome, of which 56 had erectile dysfunction at baseline. Body mass index and the presence of 1 or 2 conditions constituting the metabolic syndrome definition were the strongest predictors of the metabolic syndrome. The association of erectile dysfunction with the metabolic syndrome (unadjusted RR 1.35, 95% CI 1.01-1.81) was modified by body mass index, with a stronger effect of erectile dysfunction in men with body mass index less than 25 (adjusted RR 2.09, 95% CI 1.09-4.02), and no erectile dysfunction and metabolic syndrome association in men with body mass index 25 or greater (adjusted RR 1.06, 95% CI 0.76-1.50).
CONCLUSIONS: Erectile dysfunction was predictive of the metabolic syndrome only in men with body mass index less than 25. This finding suggests that erectile dysfunction may provide a warning sign and an opportunity for early intervention in men otherwise considered at lower risk for the metabolic syndrome and subsequent cardiovascular disease.

Entities:  

Mesh:

Year:  2006        PMID: 16753405     DOI: 10.1016/S0022-5347(06)00503-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  36 in total

Review 1.  Androgens are fundamental in the maintenance of male sexual health.

Authors:  Alvaro Morales
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

Review 2.  Urological aspects of the metabolic syndrome.

Authors:  Jan Hammarsten; Ralph Peeker
Journal:  Nat Rev Urol       Date:  2011-08-02       Impact factor: 14.432

3.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

4.  Echocardiographic Evaluation in Neonates with Heart Murmurs.

Authors:  Shokoufeh Ahmadipour; Azam Mohsenzadeh; Maryam Soleimaninejad
Journal:  J Pediatr Intensive Care       Date:  2017-12-18

5.  The inter-relational effect of metabolic syndrome and sexual dysfunction on hypogonadism in type II diabetic men.

Authors:  N Amidu; W K B A Owiredu; C K Gyasi-Sarpong; H Alidu; B B Antuamwine; C Sarpong
Journal:  Int J Impot Res       Date:  2017-03-09       Impact factor: 2.896

Review 6.  Mitochondrial adaptations evoked with exercise are associated with a reduction in age-induced testicular atrophy in Fischer-344 rats.

Authors:  A-M Joseph; L M-D Nguyen; A E Welter; J M Dominguez; B J Behnke; P J Adhihetty
Journal:  Biogerontology       Date:  2014-08-10       Impact factor: 4.277

7.  Does metabolic syndrome increase the risk of infective complications after prostate biopsy? A critical evaluation.

Authors:  Cahit Sahin; Bilal Eryildirim; A Cihangir Cetinel; Gokhan Faydaci; Fehmi Narter; Cemal Goktas; Kemal Sarica
Journal:  Int Urol Nephrol       Date:  2015-01-15       Impact factor: 2.370

8.  A population-based, longitudinal study of erectile dysfunction and future coronary artery disease.

Authors:  Brant A Inman; Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; Ajay Nehra; Michael M Lieber; Véronique L Roger; Steven J Jacobsen
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

9.  Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey.

Authors:  Varant Kupelian; Kevin T McVary; Steven A Kaplan; Susan A Hall; Carol L Link; Lalitha Padmanabhan Aiyer; Patrick Mollon; Nihad Tamimi; Raymond C Rosen; John B McKinlay
Journal:  J Urol       Date:  2009-06-18       Impact factor: 7.450

Review 10.  Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database.

Authors:  F Giuliano; G Jackson; F Montorsi; A Martin-Morales; P Raillard
Journal:  Int J Clin Pract       Date:  2009-11-09       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.